Carlos A. ARANGO FRANCO

Postdoc @crow_lab @InstitutImagine🇫🇷 PhD @casanova_lab🇫🇷| Group IEl🇨🇴Immunologist studying human genetics variations| type I-IFN autoinflammation/infectio

[BogunovicLab @BogunovicLab]

Latest from us. :)

[Carlos A. ARANGO FRANCO @carlosarangof]

Glad to have contributed to this collaborative work. Congratulations to Conor Gruber @BogunovicLab @BustamanteJaci1 and all co-authors on this @JExpMed publication.

[BogunovicLab @BogunovicLab]

Latest from us. :)

[Carlos A. ARANGO FRANCO @carlosarangof]

Honored to contribute as co-first author to this collaborative work on #CGD in Colombia 🇨🇴🧬

A study reflecting years of work, international collaboration, and above all, the resilience of patients and families.

#Immunology #PrimaryImmunodeficiency

[Journal of Human Immunity @jhumimmunity]

Clinical, microbiological and genetic analysis of 39 patients with chronic granulomatous disease in Colombia expands the regional spectrum of #CGD variants and highlights the need for earlier diagnosis and improved access to specialist testing. https://t.co/zXTEMX4vzj

[Journal of Human Immunity @jhumimmunity]

Clinical, microbiological and genetic analysis of 39 patients with chronic granulomatous disease in Colombia expands the regional spectrum of #CGD variants and highlights the need for earlier diagnosis and improved access to specialist testing. https://t.co/zXTEMX4vzj

[Anna-Lena Neehus @ALNeehus]

Excited to share our latest work published today in @NatImmunol! 🎉 Together with Taja Vatovec, we investigated how somatic CBL deficiency affects B cell development and function. https://t.co/sROc3oMXX2

[Carlos A. ARANGO FRANCO @carlosarangof]

🏆2025 Award for Highest Impact Research-Medellín Investiga
We are honored to receive this award. We identified AR-IL7 deficiency causing profound T-cell dysfunction and susceptibility to persistent HPV infection, tuberculosis, and invasive fungal diseases
https://t.co/D9Nu7vDm6y

[Carlos A. ARANGO FRANCO @carlosarangof]

@HsiehElena @casanova_lab @ANM_Colombia Thank you Elena 🙏🏼🤩

[Carlos A. ARANGO FRANCO @carlosarangof]

1/ 🎉 I am truly honored to be awarded the best PhD thesis in human health 2024 by the Colombian National Academy of Medicine @ANM_Colombia 🇨🇴

[Carlos A. ARANGO FRANCO @carlosarangof]

@ShenYingZhang1 @yihaoo @ANM_Colombia Thank you Shen-Ying ;)

[Carlos A. ARANGO FRANCO @carlosarangof]

9/ Immense gratitude to the patients and relatives, my family, and colleagues worldwide 🌍🔬🌎. Special thanks to @UdeA @BiomedicasUdeA @casanova_lab @InstitutImagine @ESIDsociety and Sapiencia from @AlcaldiadeMed Thank you all for their unwavering support and collaboration!

[Carlos A. ARANGO FRANCO @carlosarangof]

8/ This achievement would not have been possible without the incredible support of so many people. Huge thanks to my supervisors @anne_puel Andres Arias and my mentors @casanova_lab @FrancoJL_UDEA @BustamanteJaci1 @Marce_MoncadaV and Juan Alvaro Loópez

[Journal of Clinical Investigation @jclinicalinvest]

Why do some patients with a CBL genotype develop autoinflammatory disease?https://t.co/k0Wygkh1on

@Jonathan_Bohlen @casanova_lab and team report on chronic monocyte activation through the ERK pathway as a major contributor in patients with CBL LOF variants.

[Carlos A. ARANGO FRANCO @carlosarangof]

Felicitaciones to my friend @Jonathan_Bohlen for another amazing story “CBL deficiency in patients with autoinflammation”.
I am Glad to have had the chance to work with you and contributed a bit on this project! 🤩
https://t.co/rk6yupb2mx

[Jonathan Bohlen @Jonathan_Bohlen]

I’m excited to announce our new paper that came out today! The second chapter of my Post-doc @casanova_lab, published in @jclinicalinvest If you’re interested in the causes of autoinflammation, then this one is for you: https://t.co/uhVDdzqyx2 1/8